제품 정보로 건너뛰기
1 1

Cloud-clone

SKU(재고 관리 코드):PAD559Hu01

Polyclonal Antibody to Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

Polyclonal Antibody to Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

UOM
Concentration
Organism species

Western blotting: 0.5-2µg/mL
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.

Product No.

PAD559Hu01

Organism Species

Homo sapiens (Human).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

RPD559Hu01-Recombinant Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

Buffer Formulation

0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Mus musculus (Mouse), Rattus norvegicus (Rat), Sus scrofa; Porcine (Pig)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against MAP2K1. It has been selected for its ability to recognize MAP2K1 in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

Graefe's Archive for Clinical and Experimental Ophthalmology

Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome pubmed:27538909

PLOS ONE

Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients. pubmed:27824861

Cancers

Rationale for a Combination Therapy Consisting of MCL1-and MEK-Inhibitors in Acute Myeloid Leukemia Pubmed: 31718075

Cancers (Basel)

BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers 2021, 13, 581 33540760


Catalog No.

Related products for research use of Homo sapiens (Human) Organism species

Applications (RESEARCH USE ONLY!)

RPD559Hu01

Recombinant Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

Positive Control; Immunogen; SDS-PAGE; WB.

PAD559Hu01

Polyclonal Antibody to Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

WB; IHC; ICC; IP.

MAD559Hu21

Monoclonal Antibody to Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

WB; IHC; ICC; IP.

SED559Hu

ELISA Kit for Mitogen Activated Protein Kinase Kinase 1 (MAP2K1)

Enzyme-linked immunosorbent assay for Antigen Detection.

LMD559Hu

Magnetic Luminex Assay Kit for Mitogen Activated Protein Kinase Kinase 1 (MAP2K1) ,etc.

Magnetic Luminex Assay for Antigen Detection.

 

전체 세부 정보 보기